금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
British Pound Sterling gets a decent jobs report and sells off anyway
The British Pound received a labour market report on Tuesday that beat consensus on nearly every lin...
S&P 500, Dow Snap Three-Day Losses, Nasdaq Ends Best Day In Three Weeks As Earnings Take Centerstage — GOOGL, AAPL, AMD, TSLA, DIS In Focus
The Philadelphia Semiconductor Index jumped over 5%, its best single-day gain in a month, as bargain...
Wall Street ends higher on chip stocks recovery; earnings draw focus
STORY: U.S. stocks closed higher on Tuesday, with the Dow gaining roughly three-quarters of a percen...
Invesco BulletShares 2030 Corporate Bond ETF declares monthly distribution of $0.0642
Invesco BulletShares 2029 Municipal Bond ETF declares monthly distribution of $0.0534
Invesco BulletShares 2029 High Yield Corporate Bond ETF declares monthly distribution of $0.1098
Top Midday Stories: Treasury Authorizes Sale of Iranian Oil; SpaceX launches First Inaugural Bond Issuance
The Nasdaq Composite and S&P 500 were down, while the Dow Jones Industrial Average was up in late-mo
Invesco BulletShares 2029 Corporate Bond ETF declares monthly distribution of $0.0703
Invesco BulletShares 2028 Municipal Bond ETF declares monthly distribution of $0.0563
3 Big Reasons to Love JFrog (FROG)
JFrog has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14.5%. The stock now trades at $84.13, marking a 23.5% gain. This was partly thanks to its solid quart ...
Micron Leads AI Trade Higher. Expectations Are Rising Ahead of the Memory Chipmaker's Earnings.
Micron Technology led other AI hardware stocks higher to start the week, ahead of the memory chipmaker's earnings.
Should You Buy AMD Stock Now or Wait for a Dip?
AMD's stock has already more than doubled this year.
Walmart, Sam’s Club to expand Medicare support as weight-management drug coverage evolves
Dividend ETFs: How SCHD and FDVV Measure Up
Sector allocations and risk profiles set these dividend ETFs apart for investors weighing income versus long-term appreciation.
Achieve Life Sciences jumps despite cytisinicline CRL